This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Pharma Law USA
October 8 & 9 2024
The Westin Copley PlaceBoston MA

Megan Browdie
Partner at Cooley
Speaker

Profile

Megan solves clients’ antitrust issues, guiding transactions through merger review and representing clients in government investigations and litigation. She regularly counsels clients – including private equity sponsors – on a variety of topics, including pricing practices, licensing of intellectual property and other distribution issues. Megan has helped to secure critical wins for clients in a number of cases and has experience in matters before the Department of Justice, Federal Trade Commission and state antitrust authorities.

Chambers USA, Super Lawyers, Best Lawyers and Who’s Who Legal recognize Megan as a top antitrust practitioner. Chambers quotes clients describing Megan as “an expert” who is “great to work with.”

Megan works with clients in a variety of industries, including automotive, consumer goods, computer hardware, financial services, Internet of Things, oil and gas, pharmaceuticals and medical devices, publishing, software and telecommunications.

Megan also is an active member of the American Bar Association’s Antitrust Law Section. She is currently a vice chair on the Health Care and Pharmaceuticals Committee and previously served in various positions on the M&A Committee, the Federal Civil Enforcement Committee and the Presidential Transition Task Force. Megan was also as an editor for Antitrust Law Developments (Ninth Edition), the premier antitrust treatise.

Megan maintains a vibrant pro bono practice, typically representing caregivers and children in the Washington, DC area. Megan is also co-chair of Cooley’s DC Pro Bono Committee.

Agenda Sessions

  • Merger Control: Review of FTC Guidelines & Lessons Learnt from Recent Mergers

    10:00am